- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
TransFlow uses block-wise VAEs and bidirectional Flow Matching for cross-modality translation between scRNA-seq and scATAC-seq. GenePT and Gena-LM are used to group genes and peaks of ATAC-seq into blocks. Instead of starting from random noise, the Flow Matching model starts from the source modality representation and learns to transport it to the target modality. TransFlow is evaluated on BMMC, PBMC10k, and MiniAtlas. The method achieves good performance on distribution-level metrics, while improvements in feature-level prediction are less consistent. The authors also conduct ablation studies and held-out-cell-type experiments.
Critical strengths
- Initializing Flow Matching from the source modality is a reasonable design for paired multi-omics data. The ablation study shows clear improvements over noise initialization.
- The authors evaluate the method on three datasets with several baselines. TransFlow achieves good distribution matching performance in both translation directions. The held-out-cell-type experiments also provide some evidence of generalization.
Critical weaknesses
- Flow Matching has already been applied to single-cell multi-omics generation and cross-modality translation, such as in CFGen and GENOT. The main contribution is source initialization, while the bidirectional architecture is largely based on existing methods. The block-wise representation also provides only marginal improvements.
- The evaluation mainly uses standard datasets, and comparisons with existing Flow Matching approaches are not sufficiently controlled. Improvements are mostly reflected in distribution-level metrics, while feature-level prediction is less consistent. More challenging datasets and clearer examples of generated profiles would strengthen the results.
Questions for authors
- Can the authors provide a more controlled comparison with existing Flow Matching approaches, using the same latent representations and comparable architectures?
- Can the authors evaluate TransFlow on more challenging datasets, such as cross-tissue or cross-dataset translation? The current experiments mainly use standard benchmarks.
- Why does TransFlow achieve better W2 and MMD scores but not consistently better feature-level prediction (such as Row Cor. in Table 1)?
- Since the VAEs of RNA-seq and ATAC-seq are trained independently, what justifies linear interpolation between their latent representations?
- Why the results for the full TransFlow model differ between Table 1 and Table 3 on BMMC?